Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Roos S van Rijn"'
Autor:
Chantal Scheepbouwer, Ernesto Aparicio-Puerta, Cristina Gomez-Martin, Heleen Verschueren, Monique van Eijndhoven, Laurine E. Wedekind, Stavros Giannoukakos, Nathalie Hijmering, Lisa Gasparotto, Hilde T. van der Galien, Roos S. van Rijn, Eleonora Aronica, Robby Kibbelaar, Vivi M. Heine, Pieter Wesseling, David P. Noske, W. Peter Vandertop, Daphne de Jong, D. Michiel Pegtel, Michael Hackenberg, Tom Wurdinger, Alan Gerber, Danijela Koppers-Lalic
Publikováno v:
Genes & development, 37(5-6), 243-257. Cold Spring Harbor Laboratory Press
Scheepbouwer, C, Aparicio-Puerta, E, Gomez-Martin, C, Verschueren, H, van Eijndhoven, M, Wedekind, L E, Giannoukakos, S, Hijmering, N, Gasparotto, L, van der Galien, H T, van Rijn, R S, Aronica, E, Kibbelaar, R, Heine, V M, Wesseling, P, Noske, D P, Vandertop, W P, de Jong, D, Pegtel, D M, Hackenberg, M, Wurdinger, T, Gerber, A & Koppers-Lalic, D 2023, ' ALL-tRNAseq enables robust tRNA profiling in tissue samples ', Genes and Development, vol. 37, no. 5-6, pp. 243-257 . https://doi.org/10.1101/gad.350233.122
Genes and Development, 37(5-6), 243-257. Cold Spring Harbor Laboratory Press
Scheepbouwer, C, Aparicio-Puerta, E, Gomez-Martin, C, Verschueren, H, van Eijndhoven, M, Wedekind, L E, Giannoukakos, S, Hijmering, N, Gasparotto, L, van der Galien, H T, van Rijn, R S, Aronica, E, Kibbelaar, R, Heine, V M, Wesseling, P, Noske, D P, Vandertop, W P, de Jong, D, Pegtel, D M, Hackenberg, M, Wurdinger, T, Gerber, A & Koppers-Lalic, D 2023, ' ALL-tRNAseq enables robust tRNA profiling in tissue samples ', Genes and Development, vol. 37, no. 5-6, pp. 243-257 . https://doi.org/10.1101/gad.350233.122
Genes and Development, 37(5-6), 243-257. Cold Spring Harbor Laboratory Press
Transfer RNAs (tRNAs) are small adaptor RNAs essential for mRNA translation. Alterations in the cellular tRNA population can directly affect mRNA decoding rates and translational efficiency during cancer development and progression. To evaluate chang
Autor:
Olivier J. van Not, Melissa M. de Meza, Alfons J.M. van den Eertwegh, John B. Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jesper van Breeschoten, Jan-Willem B. de Groot, Geke A.P. Hospers, Rawa K. Ismail, Ellen Kapiteijn, Djura Piersma, Roos S. van Rijn, Marion A.M. Stevense-den Boer, Astrid A.M. van der Veldt, Gerard Vreugdenhil, Han J. Bonenkamp, Marye J. Boers-Sonderen, Willeke A.M. Blokx, Michel W.J.M. Wouters, Karijn P.M. Suijkerbuijk
Publikováno v:
European journal of cancer (Oxford, England : 1990), 167, 70-80. Elsevier Ltd.
van Not, O J, de Meza, M M, van den Eertwegh, A J M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, van Breeschoten, J, de Groot, J-W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Bonenkamp, H J, Boers-Sonderen, M J, Blokx, W A M, Wouters, M W J M & Suijkerbuijk, K P M 2022, ' Response to immune checkpoint inhibitors in acral melanoma : A nationwide cohort study ', European Journal of Cancer, vol. 167, pp. 70-80 . https://doi.org/10.1016/j.ejca.2022.02.026
European Journal of Cancer, 167, 70-80. ELSEVIER SCI LTD
European Journal of Cancer, 167, pp. 70-80
European Journal of Cancer, 167, 70-80
European Journal of Cancer, 167, 70-80. Pergamon
van Not, O J, de Meza, M M, van den Eertwegh, A J M, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, van Breeschoten, J, de Groot, J-W B, Hospers, G A P, Ismail, R K, Kapiteijn, E, Piersma, D, van Rijn, R S, Stevense-den Boer, M A M, van der Veldt, A A M, Vreugdenhil, G, Bonenkamp, H J, Boers-Sonderen, M J, Blokx, W A M, Wouters, M W J M & Suijkerbuijk, K P M 2022, ' Response to immune checkpoint inhibitors in acral melanoma : A nationwide cohort study ', European Journal of Cancer, vol. 167, pp. 70-80 . https://doi.org/10.1016/j.ejca.2022.02.026
European Journal of Cancer, 167, 70-80. ELSEVIER SCI LTD
European Journal of Cancer, 167, pp. 70-80
European Journal of Cancer, 167, 70-80
European Journal of Cancer, 167, 70-80. Pergamon
Background: Recent reports suggest the limited efficacy of immune checkpoints inhibitors in advanced acral melanoma (AM). This study aims to investigate the clinical outcomes of immune checkpoint inhibitors in patients with stage III and IV AM and co
Autor:
Djura Piersma, Marye J Boers-Sonderen, Geke A. P. Hospers, Karijn P M Suijkerbuijk, Christian U. Blank, Roos S. van Rijn, Astrid A M van der Veldt, Jan-Willem B de Groot, Ellen Kapiteijn, Franchette W P J van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jesper van Breeschoten, Doranne L. Hilarius, Bert-Jan J. ten Tije, Michel W.J.M. Wouters, Art Vreugdenhil, John B. A. G. Haanen, Maureen J.B. Aarts, Willeke A. M. Blokx
Publikováno v:
Br J Cancer
A Correction to this paper has been published: https://doi.org/10.1038/s41416-021-01312-1
Autor:
Alfonsus J. M. van den Eertwegh, Michel W.J.M. Wouters, Roos S. van Rijn, John B. A. G. Haanen, Maureen J.B. Aarts, Bert-Jan J. ten Tije, Karijn P M Suijkerbuijk, Christian U. Blank, Jesper van Breeschoten, Geke A. P. Hospers, Jan-Willem B de Groot, Franchette W P J van den Berkmortel, Ellen Kapiteijn, Doranne L. Hilarius, Marye J Boers-Sonderen, Djura Piersma, Art Vreugdenhil, Astrid A M van der Veldt, Willeke A. M. Blokx
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 124(7), 1222-1230. Nature Publishing Group
British Journal of Cancer, 124, 7, pp. 1222-1230
British Journal of Cancer, 124, 1222-1230
van Breeschoten, J, Wouters, M W J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, Tije, B-J J T, Veldt, A A M V D, Vreugdenhil, A, Boers-Sonderen, M J & van den Eertwegh, A J M 2021, ' First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis ', British Journal of Cancer, vol. 124, no. 7, pp. 1222-1230 . https://doi.org/10.1038/s41416-020-01229-1
British Journal of Cancer, 124(7), 1222-1230. SPRINGERNATURE
British Journal of Cancer, 124(7), 1222-1230. Nature Publishing Group
British Journal of Cancer, 124, 7, pp. 1222-1230
British Journal of Cancer, 124, 1222-1230
van Breeschoten, J, Wouters, M W J M, Hilarius, D L, Haanen, J B, Blank, C U, Aarts, M J B, van den Berkmortel, F W P J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Blokx, W A M, Tije, B-J J T, Veldt, A A M V D, Vreugdenhil, A, Boers-Sonderen, M J & van den Eertwegh, A J M 2021, ' First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis ', British Journal of Cancer, vol. 124, no. 7, pp. 1222-1230 . https://doi.org/10.1038/s41416-020-01229-1
British Journal of Cancer, 124(7), 1222-1230. SPRINGERNATURE
Contains fulltext : 232046.pdf (Publisher’s version ) (Closed access) BACKGROUND: Anti-PD-1 antibodies and BRAF/MEK inhibitors are the two main groups of systemic therapy in the treatment of BRAF(V600)-mutant advanced melanoma. Until now, data are
Autor:
Jesper, van Breeschoten, Michel W J M, Wouters, Doranne L, Hilarius, John B, Haanen, Christian U, Blank, Maureen J B, Aarts, Franchette W P J, van den Berkmortel, Jan-Willem B, de Groot, Geke A P, Hospers, Ellen, Kapiteijn, Djura, Piersma, Roos S, van Rijn, Karijn P M, Suijkerbuijk, Willeke A M, Blokx, Bert-Jan J Ten, Tije, Astrid A M van der, Veldt, Art, Vreugdenhil, Marye J, Boers-Sonderen, Alfonsus J M, van den Eertwegh
Publikováno v:
Br J Cancer
Anti-PD-1 antibodies and BRAF/MEK inhibitors are the two main groups of systemic therapy in the treatment of BRAFWe selected patients diagnosed between 2014 and 2017 with advanced melanoma and a known BRAFBetween 2014 and 2017, a total of 330 and 254
Autor:
Peter A. W. te Boekhorst, Senada Koljenović, Roos S van Rijn, Theo de Witte, Sandra van Bijnen, Petra Muus
Publikováno v:
British Journal of Haematology, 157, 6, pp. 762-3
British Journal of Haematology, 157, 762-3
British Journal of Haematology, 157(6), 762-763. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 157, 762-3
British Journal of Haematology, 157(6), 762-763. Wiley-Blackwell Publishing Ltd
Item does not contain fulltext 01 juni 2012